1-1 of 1
Valérie Camara-Clayette, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1b Study Of Everolimus (RAD001), a mTORC1 Inhibitor In Combination With Rituximab (R), In Patients With Relapsed Or Refractory Indolent CD20+ Lymphomas Or Transformed Aggressive CD20+ Lymphomas

Vincent Ribrag, Lionel Karlin, MD, Louis Terriou, MD, Thomas Gastinne, MD, Valérie Camara-Clayette, Ph.D, Steven Le Gouill, MD, PhD, Franck Morschhauser, MD, PhD, Herve Tilly, MD, Bertrand Coiffier, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5128.
https://doi.org/10.1182/blood.V122.21.5128.5128
Published: 2013